F1CT1_14 Cardiovascular Pharmacotherapy

Faculty of Pharmacy
Spring 2022
Extent and Intensity
2/1/0. 3 credit(s). Type of Completion: zk (examination).
Teacher(s)
MUDr. Tomáš Parák, Ph.D. (lecturer)
PharmDr. Lenka Paráková, Ph.D. (lecturer)
prof. MUDr. Jiří Vítovec, CSc. (lecturer)
Guaranteed by
MUDr. Tomáš Parák, Ph.D.
Department of Pharmacology and Toxicology – Departments – Faculty of Pharmacy
Supplier department: Department of Pharmacology and Toxicology – Departments – Faculty of Pharmacy
Timetable
Tue 15:45–17:25 44-037
  • Timetable of Seminar Groups:
F1CT1_14/01: each even Tuesday 17:25–19:05 44-037, T. Parák
Course Enrolment Limitations
The course is also offered to the students of the fields other than those the course is directly associated with.
The capacity limit for the course is 40 student(s).
Current registration and enrolment status: enrolled: 0/40, only registered: 0/40, only registered with preference (fields directly associated with the programme): 0/40
fields of study / plans the course is directly associated with
Course objectives
The aim of the course is to acquaint students with the current overview of individual drug groups used in cardiology and with current trends in the therapy of cardiovascular diseases. The course is more clinically oriented, where the student is allowed a clinical-medical view of the issue and the student is forced to think in a clinical context.
Learning outcomes
After completing the course, the student will be able to think in a clinical-medical context in the field of cardiovascular disease. The course is suitable for students who are interested in deepening their knowledge in the field of hospital and clinical pharmacy.
Syllabus
  • Course of lectures and seminars:
    1. Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, beta blockers
    Seminar: Clinical case studies related to the topic
    2. Calcium channel blockers, alpha-blockers, central agonists
    Seminar: Clinical case studies related to the topic
    3. Vasodilators, nitrates, diuretics
    Seminar: Clinical case studies related to the topic
    4. Cardiac glycosides, inotropic agents and sympathomimetics
    Seminar: Clinical case studies related to the topic
    5. Antithrombotics
    Seminar: Clinical case studies related to the topic
    6. Anti-arrhythmics and therapy of arrhythmias
    Seminar: Clinical case studies related to the topic
    7. Lipid lowering therapy and hyperlipidemia, and other new drugs used in cardiology
    Seminar: Clinical case studies related to the topic
    8. Therapy of hypertension and hypotension, treatment of hypertensive crisis
    Seminar: Clinical case studies related to the topic
    9. Therapy of stable angina pectoris and acute coronary syndrome
    Seminar: Clinical case studies related to the topic
    10. Therapy of acute and chronic heart failure
    Seminar: Clinical case studies related to the topic
    11. Therapy of heart inflammation - infectious endocarditis, myocarditis, pericarditis
    Seminar: Clinical case studies related to the topic
    12. Therapy of cardiomyopathy, pulmonary embolism, pulmonary hypertension
    Seminar: Clinical case studies related to the topic
    13. Therapy of stroke, venous thrombosis, ischemic disease of lower limbs
    Seminar: Clinical case studies related to the topic
    14. Therapy after orthotopic heart transplantation, treatment of erectile dysfunction
    Seminar: Clinical case studies related to the topic
Literature
    recommended literature
  • Vítovec Jiří, Špinar Jindřich, Špinarová Lenka a kolektiv. Farmakoterapie kardiovaskulárních onemocnění. Praha, 2017. ISBN 978-80-247-4713-2. URL info
Teaching methods
theoretical preparation for individual topics
Assessment methods
oral examination
Language of instruction
Czech
Further comments (probably available only in Czech)
Study Materials
The course can also be completed outside the examination period.
Teacher's information
Before the exam in Cardiovascular Pharmacotherapy, it is necessary to successfully pass the exam in Pharmacology II (course of Pharmacology at Medical Faculty). 100% attendance in seminars is obligatory.
The course is also listed under the following terms Spring 2020, Spring 2021, Spring 2024, Spring 2025.
  • Enrolment Statistics (Spring 2022, recent)
  • Permalink: https://is.muni.cz/course/pharm/spring2022/F1CT1_14